So we can expect news Monday at the opening. Here’s hoping we...

So we can expect news Monday at the opening. Here’s hoping we have some FOMO tomorrow pushing us into double figures.

1. Phase 1 Pharmacodynamic and Pharmacokinetic Study of the Geranylgeranyltransferase I Inhibitor PTX-100 (GGTI-2418) in Patients with Advanced Malignancies
   Result Type: Paper
   Number: 1705
   Presenter: H. Miles Prince
   Program: Oral and Poster Abstracts
   Session: 624. Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Poster I
   Time and Location:
   Saturday, December 9, 2023: 5:30 PM-7:30 PM
   Halls G-H (San Diego Convention Center)
   Search Result:
   
   ... K. Yannakou, MBBS (Hons), FRACP, FRCPA, PhD2*, Vinod Ganju, MBBS, FRACP3*, Steven Grant, M.D.4*, Said Sebti5* and H. Miles Prince, MD61Prescient Therapeutics, Limited, Allyn, WA2Epworth HealthCare, Melbourne, VIC, Australia3Peninsula Oncology Centre Consulting Suite, Frankston, VIC, AUS4Massey Cancer Center, Virginia Commonwealth University, ...